Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade
Authors
Keywords
COVID-19, SARS-CoV-2, Complement system, Inflammatory/immunological, Eculizumab
Journal
HUMAN IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-20
DOI
10.1016/j.humimm.2021.01.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury
- (2020) Yuntao Wu VIROLOGICA SINICA
- Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily
- (2020) Eleni Gavriilaki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complement activation in patients with COVID-19: A novel therapeutic target
- (2020) Massimo Cugno et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19
- (2020) Guoping Li et al. JOURNAL OF AUTOIMMUNITY
- The case of Complement activation in COVID-19 multiorgan impact
- (2020) Marina Noris et al. KIDNEY INTERNATIONAL
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- (2020) Sara Mastaglio et al. CLINICAL IMMUNOLOGY
- The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2
- (2020) Francesco Ferrara et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Coagulopathy in COVID‐19
- (2020) Toshiaki Iba et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- COVID-19 and hypercoagulability in the outpatient setting
- (2020) Roger Emert et al. THROMBOSIS RESEARCH
- Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option
- (2020) Philip F. Stahel et al. Frontiers in Immunology
- Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
- (2020) Luca Perico et al. Nature Reviews Nephrology
- Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
- (2020) Jan C. Holter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic Strategies for SARS-CoV-2 acting on ACE-2
- (2020) A. Vitiello et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Remdesivir versus ritonavir/lopinavir in COVID-19 patients
- (2020) Antonio Vitiello et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19
- (2020) A. Vitiello et al. LIFE SCIENCES
- Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
- (2019) Kioa Lente Wijnsma et al. CLINICAL PHARMACOKINETICS
- Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study
- (2018) Niccolò Lombardi et al. BMC Pharmacology & Toxicology
- Safety profile after prolonged C3 inhibition
- (2018) Edimara S. Reis et al. CLINICAL IMMUNOLOGY
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
- (2018) Lisa E. Gralinski et al. mBio
- Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis
- (2017) Serena Bettoni et al. JOURNAL OF IMMUNOLOGY
- Novel insights into the expression pattern of anaphylatoxin receptors in mice and men
- (2017) Yves Laumonnier et al. MOLECULAR IMMUNOLOGY
- von Willebrand factor is a cofactor in complement regulation
- (2014) S. Feng et al. BLOOD
- Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches
- (2014) Magdalena Riedl et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started